Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Diabetes
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder Trial
May 2026
Semaglutide might offer a novel treatment pathway for alcohol use disorder in those with comorbid obesity. Learn more.
Read more
7 May 2026
Semaglutide Cuts Heavy Drinking in Alcohol Use Disorder Trial
Semaglutide might offer a novel treatment pathway for alcohol use disorder in those with comorbid obesity. Learn more.
5 May 2026
Semaglutide Improved Motivation in Patients with Depression
Semaglutide improved motivation in patients with major depressive disorder, holding promise for the treatment of neuropsychiatric disorders characterised by reward dysfunction.
3 May 2026
MRI Pacinian Corpuscle Counts Signals Diabetic Neuropathy Severity
MRI Pacinian corpuscles in the forefoot may reflect diabetic sensorimotor polyneuropathy severity, with counts correlating to nerve conduction measures.
2 May 2026
SGLT2 Inhibitors Reduced Heart Transplant Rejection
A meta-analysis found SGLT2 inhibitors reduced rejection risk after heart transplantation in patients with diabetes, while other major outcomes remained unchanged.
30 Apr 2026
Type 2 Diabetes Historically More Prevalent in Indigenous Populations
Indigenous populations historically face a significantly higher prevalence of Type 2 diabetes than global averages, a new systematic review has found.
25 Apr 2026
Diet Differs by Type 2 Diabetes Subtype
Dietary patterns vary across type 2 diabetes subtypes, with links to comorbidities, highlighting the need for more personalised nutrition strategies.
23 Apr 2026
Diabetes Shoulder: Near Fourfold Higher Risk of Adhesive Capsulitis
Patients with diabetes have a near fourfold higher risk of ‘frozen shoulder’, a new systematic review and meta-analysis has found.
18 Apr 2026
Metformin May Protect Against Oesophageal Squamous Cell Carcinoma
Metformin is associated with lower odds of oesophageal squamous cell carcinoma, according to a 2026 Nordic population-based case-control study.
Loading posts...
1
2
3
…
47
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View